Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : CME Telemetrix -- Ignore unavailable to you. Want to Upgrade?

To: rdww who wrote (4)	1/15/1998 7:53:00 AM
From: stephen	Read Replies (1) \| Respond to of 12

I see the news as inconsequential. CME has other strategic relationships and are being pursued by international, big name firms. Also, one can't get too upset when Abbott is cutting out funding to all third party research and development companies, that are linked with Medisense. They have decided to go internal. Thus, their decision has nothing to do with CME or its science. Now CME can hook up with Johnson and Johnson (or someone else) and concentrate on what they are trying to accomplish. I see this news as neutral since CME was going to have to choose between partners in the short term anyway. Any other comments?